论文信息 - Experience with 2 Dose Schedules of Inotuzumab Ozogamicin, Single Dose, and Weekly, in Refractory-Relapsed Acute Lymphocytic Leukemia (ALL) - 字舞流文

Experience with 2 Dose Schedules of Inotuzumab Ozogamicin, Single Dose, and Weekly, in Refractory-Relapsed Acute Lymphocytic Leukemia (ALL)

H. Kantarjian | J. Cortes | F. Ravandi | E. Jabbour | S. O'brien | Deborah A. Thomas | J. Jorgensen | S. Faderl | P. Kebriaei | R. Garris | S. York | M. Kwari | D. Thomas | Rebecca E. Garris